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ABSTRACT The structure of a 36-amino-acid-long amino-terminal fragment of phospholamban (phospholamban[1–36]) in
aqueous solution containing 30% trifluoroethanol was determined by nuclear magnetic resonance. The peptide, which
comprises the cytoplasmic domain and six residues of the transmembrane domain of phospholamban, assumes a confor-
mation characterized by two -helices connected by a turn. The residues of the turn are Ile18, Glu19, Met20, and Pro21,
which are adjacent to the two phosphorylation sites Ser16 and Thr17. The proline is in a trans conformation. The helix
comprising amino acids 22–36 is well determined (the root mean square deviation for the backbone atoms, calculated for a
family of 18 nuclear magnetic resonance structures is 0.57 Å). Recently, two molecular models of the transmembrane domain
of phospholamban were proposed in which a symmetric homopentamer is composed of a left-handed coiled coil of -helices.
The two models differ by the relative orientation of the helices. The model proposed by Simmerman et al. (H.K. Simmerman,
Y.M. Kobayashi, J.M. Autry, and L.R. Jones, 1996, J. Biol. Chem. 271:5941–5946), in which the coiled coil is stabilized by a
leucine-isoleucine zipper, is similar to the transmembrane pentamer structure of the cartilage oligomeric membrane protein
determined recently by x-ray (V. Malashkevich, R. Kammerer, V. Efimov, T. Schulthess, and J. Engel, 1996, Science
274:761–765). In the model proposed by Adams et al. (P.D. Adams, I.T. Arkin, D.M. Engelman, and A.T. Brunger, 1995, Nature
Struct. Biol. 2:154–162), the helices in the coiled coil have a different relative orientation, i.e., are rotated clockwise by 50°.
It was possible to overlap and connect the structure of phospholamban[1–36] derived in the present study to the two
transmembrane pentamer models proposed. In this way two models of the whole phospholamban in its pentameric form were
generated. When our structure was connected to the leucine-isoleucine zipper model, the inner side of the cytoplasmic
domain of the pentamer (where the helices face one another) was lined by polar residues (Gln23, Gln26, and Asn30), whereas
the five Arg25 side chains were on the outer side. On the contrary, when our structure was connected to the other
transmembrane model, in the inner side of the cytoplasmic domain of the pentamer, the five Arg25 residues formed a highly
charged cluster.
INTRODUCTION
Phospholamban (PLB)1 is a low molecular weight protein
(52 amino acids), present in cardiac, slow-twitch, and
smooth muscle, which can be phosphorylated by both
cAMP-dependent (Karczewski et al., 1987) and Ca2/cal-
modulin-dependent (Iwasa et al., 1985) phosphokinases.
The phosphorylation/dephosphorylation of phospholamban
has been shown to regulate the Ca2-ATPase of the sarco-
plasmic/endoplasmic reticulum in myocytes (SERCA2)
(Tada and Kadoma, 1989; Jackson and Colyer, 1996). Phos-
pholamban, in its nonphosphorylated form, binds to a spe-
cific region of the large loop in the cytoplasmic domain of
SERCA2 and inhibits this pump by lowering its affinity for
Ca2, whereas the phosphorylated form does not inhibit
SERCA2 (Toyofuku et al., 1993).
It has been proposed that a region essential for functional
association of phospholamban with Ca2-ATPase lies in the
cytoplasmic domain of phospholamban (Sasaki et al., 1992;
Hughes et al., 1994a; Toyofuku et al., 1994a), whereas the
transmembrane region anchors PLB to the sarcoplasmic
membrane (Sasaki et al., 1992). However, it has been re-
cently proposed that the transmembrane region may also
exert an effect on SERCA2 (Kimura et al., 1996; Starling et
al., 1996). Moreover, evidence has been given that the
transmembrane domain of PLB induces the formation of a
PLB pentamer (Imagawa et al., 1986; Fujii et al., 1989),
which was also proposed to be a calcium ion pore (Kovacs
et al., 1988).
During the last decade, the objective has been to eluci-
date, at least partially, the secondary structure of PLB either
indirectly by means of cross-linking experiments and by
reconstitution or co-expression of SERCA2 with point-
mutated PLB (Jones and Field, 1993; Meyer et al., 1995;
Hughes et al., 1996; Simmerman et al., 1996) or directly by
circular dichroism (CD) (Simmerman et al., 1989; Terzi et
al., 1992; Vorherr et al., 1992), laser-light-scattering pho-
tometry Fourier transform infrared (FTIR) spectroscopy
(Tatulian et al., 1995; Ludlam et al., 1996), and nuclear
magnetic resonance (NMR) spectroscopy (Gao et al., 1992;
Hubbard et al., 1994; Maslennikov et al., 1995; Mortishire-
Smith et al., 1995; Quirk et al., 1996).
As PLB is an amphiphatic oligopeptide, contains three
cysteins, and is prone to pentamerization also in vitro (Sim-
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merman et al., 1986), it is not trivial to find experimental
conditions to study its structure and, in particular, an ap-
propriate solvent system that prevents nonspecific aggrega-
tion. Therefore, until now NMR studies have been carried
out either on short PLB fragments (Gao et al., 1992; Hub-
bard et al., 1994; Mortishire-Smith et al., 1995; Quirk et al.,
1996) or in organic solvents (Maslennikov et al., 1995). In
no cases is there evidence of a tertiary structure for the
cytoplasmic domain of PLB. The present investigation aims
to assess the secondary and tertiary structure of a 36-amino-
acid-long fragment of phospholamban, which comprises the
cytoplasmic domain and six amino acids of the transmem-
brane domain, in an aqueous solution.
Recently, molecular modeling and mutagenesis studies
have been used to formulate hypotheses on the quaternary
structure of the transmembrane region in the PLB pentamer,
and two models were proposed, which both show a left-
handed coiled coil (Adams et al., 1995; Simmerman et al.,
1996). The two models, however, differ by the relative
orientation of the five helices, and although in the model
proposed by Simmerman et al. the coiled coil is stabilized
by a leucine-isoleucine zipper (Simmerman et al., 1996;
Karim et al., 1998), in the model proposed by Adams et al.,
different heptad positions are packed together due to a
rotation of 50° of the helices (Adams et al., 1995). There
are no direct structural data supporting either of these mod-
els. However, the structure of another transmembrane pen-
tamer, the cartilage oligomeric membrane protein (COMP),
was recently determined by x-ray crystallography (Malash-
kevich et al., 1996), and the quaternary structure of the five
oligomers is fully consistent with the leucine-isoleucine
zipper model of PLB.
It was possible to overlap and connect the structure of
phospholamban[1–36] derived in the present study to both
of the PLB transmembrane pentamer models proposed. In
this way two models of the whole phospholamban in its
pentameric form were generated and their structure discussed.
MATERIALS AND METHODS
Peptide synthesis and purification
The 36-amino-acid amino-terminal fragment of human PLB (PLB[1–36])
was obtained by peptide synthesis by using the method described by
Vorherr et al. (1993). The peptide was purified by reverse phase high-
pressure liquid chromatography and analyzed for homogeneity by mass
spectrometry and SDS-polyacrylamide gel electrophoresis.
CD spectra were acquired at 24°C on a sample of 3 M PLB[1–36] in
H2O:D2O:perdeuterated trifluoroethanol (d3-TFE; 63:7:30) containing 6
M perdeuterated dithiothreitol (d10-DTT) at pH 3.05  0.05 (the pH
value is uncorrected for the deuterium effects). The spectra were recorded
on a Jasco J-720 spectropolarimeter using a 1-mm path-length quartz
cuvette. The band width was 1 nm, the sensitivity 20 mdeg, the step
resolution 0.5 nm, the response time 0.5 s, and the scan speed 20 nm/min
(from 270 to 190 nm). In the spectra, expressed in [] 103 degrees
cm2  dmol1, a contribution of -helix structure of 80% was calculated
from the local minimum at 220 nm.
NMR spectra
1H-NMR spectra were acquired at 400.13 MHz and at 599.86 MHz on a
Bruker ARX400 and a Varian UNITY 600 NMR spectrometer, respec-
tively. One- and two-dimensional NMR spectra were obtained for a 3 mM
solution of the 36-amino-acid fragment of PLB in the solvent mixture
H2O:D2O:d3-TFE (63:7:30) containing 6 mM d10-DTT to prevent disulfide
formation. The pH was adjusted to 3.05 0.05 (uncorrected for deuterium
isotope effects) with microliter amounts of NaOD. Correlation spectros-
copy (COSY) (Aue et al., 1976), total COSY (TOCSY) (Braunschweiler
and Ernst, 1983), and nuclear Overhauser-enhancement spectroscopy
(NOESY) (Kumar et al., 1980) (40–400 ms) spectra were recorded at 2°C,
7°C, 17°C, and 27°C, by the States-TPPI method (Marion et al., 1989b),
using a spectral width of 8.5 ppm. The two-dimensional data were
weighted and Fourier transformed to 2000 1000 real-point matrices. The
transmitter presaturated (2.0 s) residual solvent line was reduced by a
convolution difference filter technique (Marion et al., 1989a). The spectra
were referenced to the residual solvent signal (4.75 ppm at 27°C, 10
ppb/°C). A series of 10 one-dimensional spectra was acquired at different
temperatures from 2°C to 47°C.
Assignment of the NMR spectra
The spin-system and sequential assignments were derived from COSY,
TOCSY, and NOESY spectra (Wu¨thrich, 1986), acquired at 12°C, 17°C,
and 27°C. Differences in the temperature dependencies of the amido proton
chemical shifts were sufficient to unravel resonance overlap. Stereospecific
assignments for nondegenerated methylenes were deduced from coupling
constants JHH measured from the COSY spectra and from intra-residual
NOE cross-peak intensities (Chazin et al., 1988).
Structure generation and refinement
A series of NOESY spectra was acquired at 17°C with five different
mixing times (50, 80, 120, 160, and 200 ms). The integrated cross-peak
intensities (I) were used in a NOESY-built-up analysis. Distance restraints
were extracted from the initial slope of a second-order polynomial curve
fitted to the volumes of the cross-peaks integrated from the NOE series,
with the initial condition I(m0) 0. Intra-methylene and sequential NOEs
served for the calibration. The distances were initially classified as short
(1.8–2.5 Å), medium (1.8–3.5 Å), or long (3.0–6.0 Å) for the generation
of the first set of structures. When a distance could not be calculated from
the built-up curve, owing to a partial (20%) overlap, a poor signal-to-
noise ratio, or disturbances, it was required only that the distance was	5.0
Å. The upper bounds were extended by 1.0 Å for each pseudo-atom. The
restraint data were supplemented with distance restraints, which were
based on strong, medium, and weak NOEs, from the 150-ms NOE spec-
trum acquired at 12°C. In the segments characterized by NOEs typical of
-helices, the H-chemical shift of consequent residues departed from the
corresponding random coil value more than 0.2 ppm, which also implies
-helical values for the  and  dihedral angles (Wishart et al., 1991a,b).
Small 	NH (T) values suggested also that NH tends to form hydrogen bonds
most likely with backbone carbonyls in the same helix.
Coupling constants (J) were measured by the J-doubling method (McIn-
tyre and Freeman, 1992) from fine structures of COSY cross-peaks. Di-
hedrals  and 
, which were characterized by intermediate J values, were
not constrained, but small and large JNH and JHH were related to
staggered conformers (30°) on the basis of Karplus functions and intra-
residual NOEs (Karplus, 1963). The H-H distance and dihedral angle
restraints were calculated with the software FELIX (Molecular Simula-
tions). Finally, the data were imported into the software InsightII (Molec-
ular Simulations, San Diego, CA) to generate and refine the structures.
Simulated NOESY spectra were back calculated. The family of protein
structures was analyzed by the software Procheck nmr v.3.4.4 (Las-
kowski et al., 1996).
Structures were generated by distance geometry (DGII) followed by
simulated annealing (force field AMBER) (Havel et al., 1979). A set of 100
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structures was computed. Among them, 18 structures with no violations
over 0.2 Å were accepted.
The distance restraints corresponding to well resolved cross-peaks were
refined by an iterative relaxation matrix method (IRMA) based on a
structure without restraint violations (0.2 Å, 0°) (Boelens et al., 1988).
The upper bounds were kept within at least 10% of the exact distance given
by IRMA to take into account the uncertainty in correlation time c. The
refined restraint set was subsequently used to refine the coordinates by
simulated annealing (Bru¨nger et al., 1986).
Modeling of the pentamer
To create models for the whole PLB[1–52], the structure of PLB[1–36] was
overlapped and connected to both transmembrane pentamer models previ-
ously proposed. A similar approach has been recently used to connect the
structure of the cytoplasmic loops of bovine rhodopsin on the transmem-
brane -helices, whose structures were determined separately and with
other techniques (Yeagle et al., 1997).
Two models for the packing of the transmembrane domain of PLB in a
pentamer structure have been proposed (Adams et al., 1995; Simmerman et
al., 1996). The two models agree on two points, namely, 1) that the
transmembrane region (amino acids 30–52) is a symmetric homopentamer
in which the five monomers are coordinated in a left-handed coiled coil of
-helices and 2) that there is not any deviation from the -helical second-
ary structure throughout the transmembrane region. The two models differ
for the relative orientation of the five helices and for the amino acids
involved in the interhelical zippers that stabilize the pentamers. We will
refer to the model proposed by Simmerman et al. (1996) by the leucine-
isoleucine zipper model because the complex is stabilized by interactions
between leucines at one heptad position with isoleucines at another. This
packing is supported by the x-ray structure of the cartilage oligomeric
matrix protein (COMP) (Malashkevich et al., 1996) with similar heptad
assignments. The model proposed by Adams et al. (1995) differs from the
leucine-isoleucine zipper model so that each helix in the pentamer is
rotated clockwise by50°, thus leading to quite different contacts between
the helices. Both the coordinates of the model by Adams et al. and those of
COMP, analogous to the leucine-isoleucine zipper, are available from the
Brookhaven Protein Databank (structures 1psl and 1vdf, respectively)
(Bernstein et al., 1977).
PLB[1–36] was connected on the transmembrane leucine-isoleucine
zipper model (1vdf) as follows. The -carbon atoms of the residues
Gln22-Cys36 in the structure of PLB[1–36] were superimposed to the
-carbon atoms of the residues Ala30-Ala43 of 1vdf, according to the
heptad sequence alignment (Malashkevich et al., 1996). The two proteins
were fused so that Asn30 of PLB[1–36] was connected to Gln38 of 1vdf.
The unconnected parts were deleted and the carboxy terminal of 1vdf
truncated at Thr59 (residue that corresponds to Leu52 of PLB). Finally, the
side chains in the 1vdf structure were substituted by the corresponding side
chains of PLB. The derived pentamer model of PLB was refined by simple
energy minimization. The same protocol was also used to overlap and
connect the structure of PLB[1–36] on the transmembrane model proposed
by Adams et al., starting from the Brookhaven protein database file 1psl
(Bernstein et al., 1977).
All of the 18 NMR structures of PLB[1–36] with no violations over 0.2
Å could be connected to both transmembrane models as described above.
However, as the experimental root mean square deviation (rmsd) of the
backbone in the region 22–36 was below 0.6 Å, for the sake of clarity,
some of the figures illustrate only the models obtained from the structure
of PLB[1–36] with the least NOE violations. All molecular modeling was
done by the InsightII software (Molecular Simulations).
RESULTS
Assignment
The complete spin-system and sequential assignments were
obtained under the experimental conditions described. The
assignments are listed in Table 1. In addition to the cross-
peaks arising from PLB[1–36], several cross-peaks were
observed that may arise either from peptide impurities
(	5%) or from conformational isomers. No effort was made
to assign these correlations because there were no connec-
tions from the minor peaks to the main peaks.
PLB[1–36] spectra displayed chemical shift dispersion
over 8.5 ppm. Predominantly, CH shifts were at high field
as expected on the basis of the CD measurements. However,
the 	CH of the residues at the amino and carboxy termini as
well as for Glu19, Met20, and Pro21 were not shifted at
high field. Most NH shifts were confined within 1.5 ppm,
but for Glu2, Lys3, Val4 and Leu7, Gln22, and Gln23 the
NH resonances were shifted down-field. There were no
signals of methyl groups at very high field (0 ppm).
In total, 724 NOEs were assigned. All of the 34 possible
intra NH-CH correlations were observed in the fingerprint
region. Most of the corresponding NOEs were fairly strong
and comparable to sequential NHi1-CHi NOEs (Fig. 1).
Many sequential NHi-NHi1 and NHi-NHi2 NOEs were
present. Numerous CHi-NHi3 and some CHi-NHi4
NOEs were crowded in the fingerprint region of the
NOESY spectra (Fig. 2 A). Furthermore, there were a num-
ber of CHi-CHi3 cross-peaks. NOEs derived from inter-
actions longer than i i 4 were observed only for protons
of Met20.
J-couplings between NH and CH were small for most
residues. Due to overlap of resonances or weak intensity of
COSY cross-peaks it was not possible to measure accurate
values for all residues, but the couplings were below 6–7
Hz with the exception of the residues at the amino and
carboxy termini and in the center of PLB[1–36].
The high-field 	CH, the NOE values, and the small
JNH-CH values imply that residues Lys3-Ile18 and Gln22-
Phe35 are in an -helical structure. For the amino- and
carboxyl-terminal residues, the NMR data were not as abun-
dant as for the other residues, but nevertheless, the helices
extend to the termini as well (Fig. 1). A number of signif-
icant i, i  3 and i, i  4 NOEs indicate a well defined
structure at the carboxy terminus.
On the contrary, the central region of the PLB[1–36] does
not show a helical character. Namely, the 	CH values of the
residues Glu19, Met20, and Pro21 were not significantly
smaller than their random coil values. Glu19 and Met20
were mostly devoid of the NOEs typical of a helical struc-
ture, and there were unambiguous strong sequential NOEs
between CH of Glu19 and NH of Met20 and between CH
of Met20 and C	Hs of Pro21 (Fig. 2, A and B). Furthermore,
the NOE between CH of Ile18 and NH of Glu19 is strong.
All this implies that the central region of PLB[1–36] as-
sumes an extended-like conformation. The extended seg-
ment is, nevertheless, short. Thr17 and Gln22 show NOEs
and coupling constants characteristic of residues in an -he-
lix, and there are NOEs from the side chain protons of
Glu19 and Met20 to the protons of the adjacent residues in
the amino- and carboxyl-terminal helices. We conclude that
the amino- and carboxyl-terminal -helices are separated by
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a turn at Ile18, Glu19, Met20, and Pro21. The proline is in
a trans conformation. A tight turn, which would result the
axes of the amino- and carboxyl-terminal helices being
parallel, is not possible. There were no unambiguous NOEs
between the amino- and carboxyl-terminal helices.
The study of the temperature dependence of NH chemical
shifts shows that most residues with high-field 	CH have
small 
	NH (T) compared with the temperature dependence
of the water line (not shown). This suggests that these NH
are hydrogen bonded with backbone CO with the exception
of the amino-terminal residues Glu2, Lys3, and Val4, which
move with temperature. For these residues at the amino
terminus there are, of course, no -helical hydrogen bond
acceptors. We find no evidence for an end capping either. It
is difficult on the basis of the NOEs to unambiguously
distinguish between -helix and 310-helix (Wu¨thrich, 1986)
as the acceptor oxygens cannot be identified by NMR data
(Halkides and Redfiels, 1995), but we observed certain
CHi-NHi4, which imply the -helical structure.
In the carboxyl-terminal helix, the NH frequencies of
Gln22 and Gln23 clearly move with the temperature. The
NH shift of Arg25 has only small temperature dependence;
a possible hydrogen bond acceptor may in fact be the
oxygen of the peptide bond Pro21-Gln22. This is further
proof that the helical structure begins at Gln22.
In the middle of the two -helices, Leu7, Phe32, and
Ile33 have larger 
	NH (T) than the other residues. This
apparent anomaly may be explained in light of the recent
finding (Rothemund et al., 1996) that large chemical shift
temperature dependences are observed for some of the
amide protons in an -helix in the presence of TFE, possibly
due to intramolecular hydrogen bonds between TFE and the
peptic carbonyl groups. This interaction depends on solvent
accessibility and thus also on steric hindrance of the side
chains.
Also, the NH of Ile18, Glu19, and Met20 have only
modest temperature dependence. This implies that there is a
well defined turn, possibly with hydrogen bonds, or that
those NH are buried and not accessible to the solvent
(Baxter and Williamson, 1997). The side chain NH shifts
of Arg9, Arg13, and Arg14 are practically independent of
temperature, whereas 
	NH (T) of Arg25 is comparable to
TABLE 1 H-chemical shifts of PLB[1–36] in 63% H2O/7% D2O/30% d3-TFE, pH 3.05, at 17°C
Residue NH CH CH CH C	H Others
Met1 4.159 2.124 2.566 2.012
Glu2 8.803 4.572 1.967 2.510, 2.319
Lys3 8.787 4.147 1.900 1.559, 1.431 1.729 2.969
Val4 8.314 3.889 2.132 1.026, 0.951
Gln5 7.846 4.092 2.364, 2.252 2.369 7.431, 6.823
Tyr6 7.924 4.225 3.114 7.046 6.780
Leu7 8.536 4.013 1.831 1.586 0.915
Thr8 7.975 3.955 4.247 1.222
Arg9 8.156 3.518 1.845, 1.725 1.587 3.092 7.242
Ser10 7.991 4.082 3.936, 3.767
Ala11 8.051 4.085 1.510
Ile12 8.126 3.681 1.857 1.704, 1.014 0.769 0.860
Arg13 8.181 3.983 1.941, 1.735 1.606 3.162 7.189
Arg14 8.143 4.052 1.941, 1.733 1.725, 1.604 3.169 7.154
Ala15 8.422 4.114 1.500
Ser16 8.110 4.275 4.029, 3.979
Thr17 7.695 4.316 4.373 1.270
Ile18 7.589 4.102 1.925 1.576, 1.216 0.851 0.912
Glu19 8.149 4.351 2.121, 2.011 2.468, 2.426
Met20 7.958 4.702 2.088 2.544 2.027
Pro21 4.487 2.539, 2.483 2.082, 1.948 3.876, 3.591
Gln22 8.766 4.008 2.173 2.438 7.433, 6.742
Gln23 8.954 4.079 2.084, 1945 2.464 7.457, 6.784
Ala24 7.455 4.155 1.474
Arg25 7.858 3.944 1.876, 1712 1.604 3.246, 3.181 7.253
Gln26 8.143 4.019 2.136, 2.115 2.461, 2.374 7.371, 6.721
Lys27 7.647 4.069 1.954, 1.598 1.613, 1.465 1.682 2.937, 7.604
Leu28 8.099 4.063 1.773, 1.712 1.510 0.849, 0.818
Gln29 8.212 3.985 2.198, 2.117 2.480, 2.367 7.172, 6.668
Asn30 7.908 4.482 2.884, 2.803 7.486, 6.821
Leu31 7.878 4.154 1.718, 1.625 1.557 0.859, 0.797
Phe32 8.162 4.430 3.238, 3.096 7.173 7.197
Ile33 7.974 3.986 1.930 1.611, 1.283 0.900 0.891
Asn34 7.801 4.570 2.588, 2.511 7.337, 6.759
Phe35 8.006 4.694 3.272, 3.058 7.277 7.207
Cys36 7.727 4.452 2.890
The staggered conformations are denoted by a line under the chemical shift of CH if they had been proven to be in an anti-configuration to CH.
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that of water. Frequencies of glutamine and asparagine
side-chain NH2 have temperature dependences that are only
half of that of water. Based on the pitch of the -helix there
are, according to the secondary structure alone, many po-
tential hydrogen bond acceptors in the side chains both in
the amino- and carboxyl-terminal helices that may tempo-
rally take part in hydrogen bonds and result in moderate
temperature dependences for the NH2 shifts.
We followed also the temperature effect on the protons
HH of the four arginine residues; two peaks are resolved at
FIGURE 1 Summary of observed sequential and medium-range NOE connectivities for PLB[1–36] in 63% H2O/7% D2O/30% d3-TFE, pH 3.05, at 17°C
from NOESY spectra acquired at 120-, 160, and 200-ms mixing times. Sequential NOEs are represented by shaded blocks. Medium-range NOEs are
represented by arrows connecting the appropriate residues. Open circles denote 3JNHCH coupling constants smaller than 6 Hz. The secondary shift (
	)
of CH is defined as the difference between the observed chemical shift and the random coil chemical shift for each residue (Wu¨thrich et al., 1983;
Wu¨thrich, 1986). Negative (upfield) 
	 values are associated with -helical secondary structure and positive (downfield) 
	 values with -structure
(Wishart et al., 1992).
FIGURE 2 Expansions fromNOESY
spectra acquired at 17°C at 160-ms
mixing times on 3 mM PLB[1–36] in
63% H2O/7% D2O/30% d3-TFE, pH
3.05, in the presence of 6 mM d10-
DTT. (A) Fingerprint region. The
cross-peaks generated by the correla-
tions NHiCHi are marked. (B) Re-
gion showing cross-peaks from the
turn Glu19, Met20, Pro21.
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2°C, which then coalesce and become one sharp peak at
47°C. The fact that no anomalies are observed from this
classical behavior suggests that no strong hydrogen bonds
are formed by the terminal protons of arginines in PLB[1–36].
Structure of PLB[1–36]
The structure of PLB[1–36] was determined from 599 dis-
tances and 50 dihedral restraints, excluding those that were
defined more accurately by the covalent structure alone.
These redundant NOE-derived restraints were consistent
with the covalently imposed distance limits, which indi-
cated that the calibration of distances was reasonable. On
the average there were 16.6 nontrivial NOE-derived re-
straints per residue. The residues Lys3-Ile18 of the amino-
terminal helix had on the average a few restraints fewer per
residue than the residues Gln22-Cys36 in the carboxyl-
terminal helix. This is at least partly due to the fact that there
were on average more protons with nondegenerated shifts
per residue in the carboxyl-terminal helix than in the amino-
terminal helix (Table 1). For the residues Ile18-Pro21,
which confine the turn, there were about as many restraints
per residue as there were for the residues in the amino-
terminal helix.
The structure generation resulted in a family of structures
all of which show two -helices connected by a turn. The
rmsd was computed from the family of 18 structures with no
distance violations above 0.2 Å and no dihedral violations
(Fig. 3). The small distance restraint violations occurred
primarily among the side-chain groups, e.g., methyls and
amines. This may be a result of excessive mobility in these
parts, which could give rise to nonsimultaneous NOEs.
The mutual orientation of the helices was constrained
only by the short-range distance restraints in the turn. There-
fore, rmsd per residue was computed separately 1) for the
amino-terminal helix (amino acids 1–17) and 2) for the
carboxyl-terminal helix (22–36). The rmsd represented
roughly an inverse correlation with the number of restraints
per residue, as expected (Fig. 3). On the average, the atoms
in the amino-terminal helix were defined to a precision of
0.9 Å (backbone only) and of 2.1 Å (all atoms) and in the
carboxyl-terminal helix to a precision of 0.6 Å (backbone
only) and of 1.6 Å (all atoms) (Table 2). When the hydrogen
bond restraints were not imposed, NHi4 and COi were
predominantly coordinated so that hydrogen bonds can
form. This gives the rationale for the weak temperature
dependence of the NH chemical shifts for Thr8-Ile18 and
Arg25-Leu31. Accordingly, the comparatively large 	NH
(T) for Glu2-Val4 as well as for Gln22 and Gln23 are due to
the fact that for these residues at the beginning of amino-
and carboxyl-terminal helices there are no suitable hydro-
gen bond acceptors in the backbone. Quite unusual is the
large and positive 
	NH (T) of Ala24 as it cannot find a
hydrogen bond donor from the backbone. However, accord-
ing to the structure, it is possible that the NH of Ala24 forms
a hydrogen bond with the side-chain CO of Gln23. Alter-
nately, the 	NH of Ala24 is shielded in the proximity of the
side chain of Pro21, which is tilted toward Ala24 above the
axis of the carboxyl-terminal helix.
The turn is confined within four residues: Ile18, Glu19,
Met20, and Pro21. Despite the number of restraints found in
that region, there is a structural dispersion owing to impre-
cision of the short distance restraints. The smallest number
of distance violations (below 0.2 Å) were observed for
FIGURE 3 Quality of the structure of PLB[1–36] obtained by NOE data: rmsd per residue and number of restraints per residue
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structures in which the segment from C of Glu19 to C of
Pro21 is extended, the side chain of Met20 protrudes ap-
proximately parallel to the carboxyl-terminal helix, and the
side chain of Glu19 points almost in the opposite direction.
In these structures, the plane of the peptide bond Ile18-
Glu19 is nearly orthogonal to the plane of the extended
segment.
Owing to the structural imprecision in the turn, the family
of structures displays a dispersion in the relative position of
the amino- and carboxyl-terminal helices. The dispersion is,
nevertheless, limited. When the different structures of the
family are superimposed on the C of the residues in the
carboxyl-terminal helix, the amino-terminal helix is dis-
persed in a cone with an opening of approximately 80° (Fig.
4). The interhelix angle is 80  20° (n  18). Similar
mutual orientations for two sequential helices, one of which
is transmembrane and the other amphipathic, have been
found or suggested for many small membrane-bound pro-
teins or peptides (Stopar et al., 1996).
In some of the structures, the side-chain NH of Arg9,
Arg13, and Arg14, whose chemical shifts are nearly inde-
pendent of T, make hydrogen bonds with the adjacent side-
chain oxygen of Ser10, Ser16, and Thr17. For Arg25, with
large 
	NH (T), there were no obvious candidates for hy-
drogen bond donors. The side-chain NH2 of the glutamines
and asparagines could form hydrogen bond networks par-
allel to the helical axis.
With regard to the phosphorylation of PLB, we find
important that the phosphorylation site Ser16 is readily
accessible and exposed to the solvent. Thr17, on the amino-
terminal helix, is facing the carboxyl-terminal helix and
appears less exposed to the solvent than Ser16. Due to the
pitch of the -helix, Arg13 and Arg14 are also exposed with
orientations that lag 60° in phase with respect to Ser16 and
Thr17 on the same side of the helix.
Model of the PLB pentamer
The structure of PLB[1–36] proposed in this paper has
strong -helix characteristics throughout the amino acid
22–36 region (see Table 2). On the other side, both of the
models proposed in literature for the packing of the trans-
membrane domain of PLB in a pentamer structure agree that
there is not any deviation from the -helical secondary
TABLE 2 Characteristics of the structures of PLB[1–36]
Parameter Value
Distance restraints
Total 724
Short-range 385
Medium-range (i  4) 333
Long-range (i  4) 6
Dihedral restraints 32
Restraint violations/structure
Distance of 0.5 Å 0.1
Distance of 0.3 Å 2.4
Distance of 0.1 Å 26.5
rmsd (Å) for region 1–17
Backbone atoms 0.93  0.22
All atoms 2.09  0.26
rmsd (Å) for region 22–36
Backbone atoms 0.57  0.12
All atoms 1.62  0.14
 and  in core or allowed 97%
Data were computed from a family of 18 structures selected on the basis of
the analysis by PROCHECK-NMR (Laskowski et al., 1996).
FIGURE 4 Structures of PLB[1–36] deduced from NMR data. (A and B)
Orthogonal view of 18 structures with no violations0.2 Å, superimposed
on the C of the residues in the carboxyl-terminal helix. The amino-
terminal helix is dispersed in a cone with an opening of approximately 80°.
The interhelix angle is 80  20° (n  18). (C) The structure with least
NOE violations (three violations 0.1 Å, no violations 0.2 Å). Some of
the side chains are marked.
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structure throughout the transmembrane region (amino ac-
ids 30–52). With this rationale, we overlapped and con-
nected our structure to the transmembrane models by using
the common region (amino acids 30–36, -helical both in
the 36-mer and in the transmembrane models) as a handle as
described in Materials and Methods. In both of the resulting
models of the whole PLB[1–52] the -helices continue
unperturbed from Gln22 to Leu52 (Fig. 5).
In our NMR structure of PLB[1–36], despite a structural
imprecision in the turn (amino acids 18–21), the family of
structures displays a limited angular dispersion in the rela-
tive position of the amino- and carboxyl-terminal helices
(see Fig. 4, A and B). Such structures could be easily
connected with both of the transmembrane models proposed
in the literature; in both cases, in fact, the amino-terminal
helices are directed toward the outer perimeter of the pen-
tamer (as shown in Fig. 5). It can be observed that in the
pentamer based on the leucine-isoleucine zipper model the
cytoplasmic part of the pore (from amino acids 22 to 30) is
exclusively lined by polar residues (Gln 22, Gln23, Gln26,
and Asn30), which can form a net of H bonds (Fig. 5 E)
although no steric or electrostatic overlapping occurs.
Moreover, every Arg25 is facing toward the outer perimeter
(Fig. 5 C). In the other case, when the PLB[1–52] pentamer
model was obtained by using the model of Adams et al. as
a scaffold, the inner side of the cytoplasmic part shows five
residues of Arg25 that face one another, thus forming a
highly charged cluster (Fig. 5 D).
In both models, there is not any evidence for a preferred
structure in which the amino-terminal helices assume a
constrained position relative to the carboxy termini, and
every monomer maintains its flexibility near the turn (amino
acids 18–21).
DISCUSSION
The role of PLB in the regulation of SERCA was known
(Katz et al., 1975; Kirchberger et al., 1975; Hicks et al.,
1979) well before its primary structure was deduced a
decade ago from the amino acid (Simmerman et al., 1986)
and DNA (Fujii et al., 1987) sequences. However, both the
mechanism by which PLB inhibits SERCA and whether
PLB may have other physiological roles in the regulation of
Ca2 sequestration in cardiac sarcoplasmic reticulum (SR)
remain under debate. Moreover, also the relative physiolog-
FIGURE 5 Models of PLB[1–52] pentamer obtained by connecting the structure of PLB[1–36] deduced from the NMR data of the present paper to the
structures of the transmembrane PLB pentamer described in the literature. (A) The family of 18 NMR-derived structures of PLB[1–36] are shown as
superimposed on the PLB transmembrane model stabilized by a leucine-isoleucine zipper. Only two monomers facing each other (monomers 1 and 3) are
shown for clarity. Residues L37, I40, L44, I47, and L51 are shown in green. (B and C) Orthogonal views of the same PLB pentamer model as in A. For
clarity, only the NOE-derived structure of PLB[1–36] with least violations (three violations 0.1 Å, no violations 0.2 Å) is shown. (D) PLB pentamer
model derived by using the transmembrane model by Adams et al. (1995). In C and D, the position of the guanidino groups (the NH atoms) of Arg25 are
highlighted by green balls. (E) The cytoplasmic part of the PLB pentamer model shown in B and C. The side chains of Gln22, Gln23, Gln26, and Asn30
are shown. Only four monomers are shown for clarity.
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ical roles of the different domains of PLB is currently
debated; on one side it has been shown that 1) the cytoplas-
mic part of PLB has a role in the inhibition of SERCA2 via
an association with a well defined region of the calcium
pump (Toyofuku et al., 1993, 1994a,b) and that 2) the
positively charged arginines located on the cytoplasmic
domain of PLB are involved in such association (Hughes et
al., 1994a). However, on the other side it has been shown
that also the transmembrane domain of PLB plays a role not
only in the anchoring of the peptide to the membrane but
also in affecting the KCa of SERCA (Sasaki et al., 1992;
Kimura et al., 1996). Moreover, data were recently pre-
sented that show that PLB[26–52] in functional reconstitu-
tion of recombinant PLB with skeletal SERCA appeared to
uncouple ATPase activity from calcium transport, whereas
PLB[1–31] had little effect in comparison with PLB[1–52]
(Reddy et al., 1995) or even that the cytoplasmic fragment
PLB[2–25] is insufficient to inhibit SERCA (Jones and
Field, 1993) if not acetylated at Met1 (Starling et al., 1996).
As regards other possible physiological roles of PLB, it
has been proposed that the pentameric PLB may form a pore
permeable to Ca2 (Kovacs et al., 1988), which might
possibly regulate the Ca2 sequestration process, even if the
pentameric structure does not appear essential for PLB
inhibitory activity of SERCA2; in fact, a monomeric mutant
co-expressed with SERCA does inhibit the pump (Toyofuku
et al., 1994a). Recent data obtained by electron paramag-
netic resonance on the PLB/lipid complexation in the mem-
brane support a new hypothesis: namely, that the phosphor-
ylation of PLB stabilizes the pentameric form, this being the
inactive one, whereas the unphosphorylated pentamer is in
rapid equilibrium with the active monomer (Cornea et al.,
1997). Such a hypothesis was confirmed by the experiments
of Autry and Jones on functional co-expression of canine
cardiac Ca2 pump and PLB (in pentamer or monomeric
mutant forms) (Autry and Jones, 1997). These authors con-
cluded that the PLB monomer is the active species in
SERCA2 inhibition. Concurrently, it was also shown that
the inhibition function of PLB is activated by depolymer-
ization (Kimura et al., 1997).
Regarding the structural studies, it has been shown by CD
that PLB has a secondary structure rich in -helix (Sim-
merman et al., 1989; Vorherr et al., 1992). Furthermore,
several groups have obtained detailed structural data by
NMR for small fragments of PLB, in which higher percent-
ages of random coil were found, due to the terminal effect.
PLB[1–20] in water does not show any evidence of -helix
structure, whereas PLB[1–25] shows 60% -helix in 50%
TFE and 75% -helix only in 100% TFE (Hubbard et al.,
1994). The same fragment in water/30% TFE was shown to
have -helix structure from amino acids 1 to 17, but random
coil from 18 to 25 (Mortishire-Smith et al., 1995). The
structure of a PLB[1–52] point-mutated Cys413Phe mono-
mer in chloroform/methanol at room temperature was also
resolved by NMR. In this case, however, the nature of the
solvent induced a conformation where P21 did not break a
50-amino-acid-long -helix (Maslennikov et al., 1995).
The present paper shows how PLB[1–36], which com-
prises the cytoplasmic domain and six amino acids of the
transmembrane domain of phospholamban, assumes a con-
formation characterized by a high -helical content (80%),
without any evidence for residues in the -strand. These
data are in disagreement with the model proposed by Tatu-
lian et al. (1995) based on FTIR results of phospholamban
in lipid bilayer and Chou-Fasman prediction, in which the
residues 22–32 form an antiparallel -sheet. We acknowl-
edge that the use of 30% TFE in our experiment may
increment the -helical content of the peptide. However,
TFE is commonly used to stabilize -helices in peptides that
are fragments of helical regions of larger proteins (Dyson et
al., 1992; So¨nnichsen et al., 1992; Mortishire-Smith et al.,
1995). Moreover, the number of residues with -helical
characteristics found by NMR and CD in our sample at pH
3.05 and in the presence of 30% TFE is consistent with that
found earlier (40/52) by FTIR spectroscopy on a sample of
PLB[1–52] reconstituted in a bilayer membrane starting
from a solution at pH 7.4 (Ludlam et al., 1996). It appears
thus that the titration of the carboxy terminus and of the side
chains of Glu2 and Glu19 to their un-ionized form at pH
3.05, needed to maintain PLB in solution, does not cause an
overall modification of the structure. It can be added that, as
our strategy was to overlap and connect the carboxy termi-
nus of our PLB[1–36] structure to the transmembrane mod-
els, it is not improper that the carboxy terminus is in its
noncharged form.
The observation that the amino-terminal portion of PLB
forms a less stable helix than does the carboxyl-terminal
portion (see Table 2) is in agreement with the data obtained
for PLB in chloroform/methanol (Maslennikov et al., 1995).
Moreover, the strong upfield change of the chemical shifts
of CH (Fig. 2, 
	) shown for the carboxyl-terminal resi-
dues of the fragment suggests that there is no perturbation in
the -helix from residue Gln22 to the transmembrane
domain.
It was shown that the structures of the fragments PLB[1–
20] and PLB[9–20] in phosphorylated and unphosphory-
lated forms, in water and at pH 5.6, differ markedly only in
the neighborhood of Ser16 and Arg14 (Quirk et al., 1996),
whereas, according to other authors, the phosphorylation
does induce more extensive changes in the conformation of
larger amino-terminal fragments of PLB (Mortishire-Smith
et al., 1995). The orientations of Ser16, Thr17, Arg9, Arg13,
and Arg14 in the model proposed in the present paper are
not in disagreement with the hypothesis that the phosphate
group in the phosphorylated PLB will disrupt the associa-
tion with SERCA by masking the positive charges of the
arginine residues. The role of those positive charges in the
mechanism of action of PLB seems to predominate over any
other structural characteristics, as also polycations such as
spermine or poly (L-Arg) do inhibit SERCA2 (Hughes et al.,
1994a,b, 1995). Moreover, it has been shown that melittin
(an analogue of the cytoplasmic part of phospholamban)
inhibits the SERCA in skeletal SR via electrostatic cross-
linking (Voss et al., 1995).
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In our model, the positive charged residues in the amino-
terminal helix face the carboxyl-terminal helix. This may
indicate that to interact with SERCA2, PLB should assume
a prolonged position (i.e., the axes of two -helices should
be nearly parallel), whereas in the bent conformation those
charges would not be exposed to the ATPase but eventually
to the surface charges of the phospholipid bilayer. We
suggest that the apparently loose relative positioning of the
two helices around the mobile central hinge could be thus a
functional feature of PLB. This flexibility may explain also
why, in organic solvent, PLB can assume a prolonged
structure (Maslennikov et al., 1995).
Structure of the pentamer model
When comparing the two PLB[1–52] pentamer models de-
rived alternatively from the leucine-isoleucine zipper model
and from the model proposed by Adams et al., it appears
clear that the latter is energetically more unfavorable due to
the presence of the cluster of positive charged Arg25,
whereas in the former the same residues are facing outside.
Recently, a very careful re-examination of all of the exper-
imentally measured effects of systematic single-site muta-
tions on the phospholamban pentamer allowed to generate
molecular models of the transmembrane domain (Herzyk
and Hubbard, 1998), and also these data support the hy-
pothesis that the leucine-isoleucine model is likely to be the
correct one.
In addition, it can be observed that in the PLB[1–52]
pentamer derived from the leucine-isoleucine zipper model
the Arg25 charged side chains are facing toward the phos-
phorylation sites Ser16 and Thr17 of a neighboring mono-
mer. It is thus conceivable that, after phosphorylation, the
pentamer may adopt a compact conformation where Arg25
interacts with the phosphate groups of a neighboring mono-
mer. This would be in agreement with the hypothesis that
the phosphorylation of PLB stabilizes the pentamer (Cornea
et al., 1997).
In the unphosphorylated form described in the present
paper, however, there is not any evidence for a structure in
which the amino-terminal helices assume a constrained po-
sition relative to the carboxy termini, and every monomer
appears to maintain its flexibility near the turn (amino acids
18–21). This flexibility may be important in the kinetics of
the monomer-pentamer association, in phosphorylation and
dephosphorylation reactions, and in the association of PLB
monomer and/or pentamer with SERCA2. An interesting
feature in the pentamer model is the clustering of asparag-
ines and glutamines in the cytoplasmic part of the putative
ion channel. In fact, whereas the inner side of the monomers
in their transmembrane segment is lined by lipophilic resi-
dues, the inner side in the cytoplasmic segment of the
carboxyl-terminal -helix is lined by polar residues.
In the COMP pentamer structure (Malashkevich et al.,
1996), one of the interacting heptad positions is occupied by
Gln54, the side chains of which form an internal ring
interlocked by hydrogen bonds between O1 and N2 of
neighboring residues, which would stabilize the COMP
pentamer. Moreover, such a cluster is described as an ion
trap, which could bind chloride anions. We found the same
arrangement in the cytoplasmic part of the PLB pentamer
model derived from the COMP scaffold. It could be thus
hypothesized that the polar residues in the cytoplasmic part
of the channel in the PLB pentamer may play a role in its
function by selectively facilitating the leakage of calcium
ions through the sarcoplasmic reticulum during the relax-
ation period of the heart cycle. However, it seems not likely
that these residues could give a significant contribution to
the overall stability of the pentamer, as it was shown that a
single alanine mutation of the polar residues Gln22, Gln23,
Gln26, and Asn30 do not destabilize it (Fujii et al., 1989;
Simmerman et al., 1996).
On the other hand, the amino-terminal helix of PLB has
some homologies with melittin, an amphipathic peptide
that, among other properties, inhibits SERCA2 (Voss et al.,
1995) and interacts with lipid bilayers forming channels
(Bechinger, 1997; Kleinschmidt et al., 1997). It was re-
cently shown that melittin is preferably oriented parallel to
the phospholipids membrane (Kleinschmidt et al., 1997), in
a position that the amino-terminal helix of PLB is also
allowed to assume both in monomer and in pentamer form.
It remains to be seen which contribution to the channel-
forming characteristic of PLB is given by its amino-terminal
helix.
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